MiMedx Group, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US6024961012
USD
6.86
0.14 (2.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
348.88
321.48
267.84
258.62
248.23
299.25
359.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
348.88
321.48
267.84
258.62
248.23
299.25
359.11
Raw Material Cost
61.71
56.49
50.55
46.68
44.16
51.61
43.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.54
6.46
5.02
4.98
7.94
4.71
0.00
Selling and Distribution Expenses
224.54
210.33
207.43
196.08
177.61
190.71
252.65
Other Expenses
0.95
0.59
0.74
1.21
0.34
0.64
1.58
Total Expenditure (Excl Depreciation)
298.27
279.19
270.39
259.81
233.14
253.47
311.71
Operating Profit (PBDIT) excl Other Income
50.599999999999994
42.300000000000004
-2.6
-1.2
15.1
45.8
47.400000000000006
Other Income
2.37
-0.03
-0.00
-0.02
-0.00
0.28
0.53
Operating Profit (PBDIT)
64.72
40.52
-10.68
1.17
-36.54
-11.90
3.52
Interest
2.54
6.46
5.02
4.98
7.94
4.71
0.00
Exceptional Items
-1.85
0.00
0.00
-0.05
-9.23
-0.45
0.00
Gross Profit (PBDT)
287.17
264.99
217.29
211.94
204.07
247.64
315.81
Depreciation
3.04
3.43
4.05
6.17
7.84
8.53
6.92
Profit Before Tax
57.29
30.63
-19.75
-10.04
-61.54
-25.59
-3.40
Tax
15.30
-36.81
0.21
0.25
-12.26
-0.01
26.58
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
42.00
67.44
-19.95
-10.29
-49.28
-25.58
-29.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
42.00
67.44
-19.95
-10.29
-49.28
-25.58
-29.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
42.00
67.44
-19.95
-10.29
-49.28
-25.58
-29.98
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
193.11
142.72
-17.99
0.08
-0.15
34.40
49.66
Earnings per share (EPS)
0.28
0.32
-0.33
-0.15
-0.77
-0.24
-0.28
Diluted Earnings per share
0.28
0.32
-0.33
-0.15
-0.77
-0.24
-0.28
Operating Profit Margin (Excl OI)
17.0%
11.55%
-5.5%
-1.93%
-17.87%
-6.92%
-1.09%
Gross Profit Margin
17.29%
10.59%
-5.86%
-1.49%
-21.63%
-5.7%
0.98%
PAT Margin
12.04%
20.98%
-7.45%
-3.98%
-19.85%
-8.55%
-8.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 8.52% vs 20.05% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -37.69% vs 437.00% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 54.07% vs 478.50% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -61.54% vs 30.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of MiMedx Group, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
348.88
687.80
-338.92
-49.28%
Other Operating Income
0.00
0.00
0.00
Total Operating income
348.88
687.80
-338.92
-49.28%
Raw Material Cost
61.71
306.50
-244.79
-79.87%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.54
12.20
-9.66
-79.18%
Selling and Distribution Expenses
224.54
315.10
-90.56
-28.74%
Other Expenses
0.95
1.40
-0.45
-32.14%
Total Expenditure (Excl Depreciation)
298.27
647.80
-349.53
-53.96%
Operating Profit (PBDIT) excl Other Income
50.61
40.00
10.61
26.52%
Other Income
2.37
9.00
-6.63
-73.67%
Operating Profit (PBDIT)
64.72
94.50
-29.78
-31.51%
Interest
2.54
12.20
-9.66
-79.18%
Exceptional Items
-1.85
-440.10
438.25
99.58%
Gross Profit (PBDT)
287.17
381.30
-94.13
-24.69%
Depreciation
3.04
45.50
-42.46
-93.32%
Profit Before Tax
57.29
-403.30
460.59
114.21%
Tax
15.30
-17.00
32.30
190.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
42.00
-386.30
428.30
110.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
42.00
-386.30
428.30
110.87%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
42.00
-386.30
428.30
110.87%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
193.11
828.50
-635.39
-76.69%
Earnings per share (EPS)
0.28
-8.52
8.80
103.29%
Diluted Earnings per share
0.28
-8.52
8.80
103.29%
Operating Profit Margin (Excl OI)
17.00%
5.82%
0.00
11.18%
Gross Profit Margin
17.29%
-52.02%
0.00
69.31%
PAT Margin
12.04%
-56.16%
0.00
68.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 34.89 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 8.52% vs 20.05% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 4.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -37.69% vs 437.00% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.24 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 54.07% vs 478.50% in Dec 2023

Annual - Interest
Interest 0.25 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -61.54% vs 30.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.00%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023